GCL
PTLA

Glazer Capital LLC’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Glazer Capital LLC’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-613,594
Closed -$11M – 334
2020
Q2 		$11M Buy
+613,594
New +$8.54M 0.78% 45

Glazer Capital LLC's PTLA Position: Q3 2020 in Review

Glazer Capital LLC sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 613,594 shares — an estimated $11M sold.

Glazer Capital LLC first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $11M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Glazer Capital LLC reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Glazer Capital LLC sold 613,594 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $11M.
  • Glazer Capital LLC first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • Glazer Capital LLC's Portola Pharmaceuticals, Inc. position peaked at $11M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Glazer Capital LLC's 13F filing for Q3 2020, filed 13 Nov 2020.